Get alerted on the PharmaSources E-Newsletter and Pharma Sources Insight E-Compilation!
Note: You can unsubscribe from the alerts at any time.
Advertising

FDA agrees to review Merck and Pfizer’s sBLA for Bavencio and Inlyta

pharmaceutical-technologyFebruary 13, 2019

Tag: FDA , Merck , Pfizer , sBLA

PharmaSources Customer Service